Epithelial Ovarian Cancer: A Five Year Review

Medicina (Kaunas). 2023 Jun 21;59(7):1183. doi: 10.3390/medicina59071183.

Abstract

Ovarian cancer is a malignant disease that affects thousands of patients every year. Currently, we use surgical techniques for early-stage cancer and chemotherapy treatment combinations for advanced stage cancer. Several novel therapies are currently being investigated, with gene therapy and stem cell therapy being the corner stone of this investigation. We conducted a thorough search on PubMed and gathered up-to-date information regarding epithelial ovarian cancer therapies. We present, in the current review, all novel treatments that were investigated in this field over the past five years, with a particular focus on local treatment.

Keywords: cancer; gene therapy; local treatment; ovarian cancer; prognostic factors.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Carcinoma, Ovarian Epithelial / drug therapy
  • Carcinoma, Ovarian Epithelial / surgery
  • Chemotherapy, Adjuvant
  • Drug Therapy, Combination
  • Female
  • Humans
  • Ovarian Neoplasms* / pathology

Substances

  • Antineoplastic Agents

Grants and funding

This research received no external funding.